{"id":"https://openalex.org/W7216796276","doi":null,"title":"Patterns of psychotropic drug prescribing to children and adolescents attending Australian general practices from 2011 to 2018","display_name":"Patterns of psychotropic drug prescribing to children and adolescents attending Australian general practices from 2011 to 2018","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W7216796276"},"language":"en","primary_location":{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/145986","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2440/145986","pdf_url":"https://digital.library.adelaide.edu.au/server/api/core/bitstreams/bf8fa4ce-337f-41fd-8e31-419121641bb7/content","source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://digital.library.adelaide.edu.au/server/api/core/bitstreams/bf8fa4ce-337f-41fd-8e31-419121641bb7/content","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5155085789","display_name":"Julie Marie Klau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Klau, Julie Marie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5155085789"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.8057000041007996,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.8057000041007996,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.08489999920129776,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.04769999906420708,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psychotropic-prescribing","display_name":"psychotropic prescribing","score":0.8930000066757202},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.949999988079071},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.8109999895095825},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8389999866485596},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.8299999833106995},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.9549999833106995},{"id":"https://openalex.org/keywords/melatonin","display_name":"melatonin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.9890000224113464},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.6859999895095825},{"id":"https://openalex.org/keywords/social-deprivation","display_name":"social deprivation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/adverse-event-surveillance","display_name":"adverse event monitoring","score":0.8320000171661377},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.5099999904632568},{"id":"https://openalex.org/keywords/australia","display_name":"Australia","score":0.5899999737739563},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8475000262260437},{"id":"https://openalex.org/C2993714069","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychotropic drug","level":3,"score":0.6593000292778015},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6238999962806702},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5982000231742859},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4417000114917755},{"id":"https://openalex.org/C2984752397","wikidata":"https://www.wikidata.org/wiki/Q3259956","display_name":"Primary care","level":2,"score":0.44040000438690186},{"id":"https://openalex.org/C3017736306","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychotropic medication","level":3,"score":0.4390999972820282},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41990000009536743},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.3700999915599823},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3668000102043152},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35530000925064087},{"id":"https://openalex.org/C2777673361","wikidata":"https://www.wikidata.org/wiki/Q5281228","display_name":"Disadvantage","level":2,"score":0.3294000029563904},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.32190001010894775},{"id":"https://openalex.org/C134362201","wikidata":"https://www.wikidata.org/wiki/Q317309","display_name":"Mental health","level":2,"score":0.3199999928474426},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.3107999861240387},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.30309998989105225},{"id":"https://openalex.org/C2910723583","wikidata":"https://www.wikidata.org/wiki/Q65066344","display_name":"Drug Utilization Review","level":3,"score":0.29750001430511475},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2854999899864197},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.273499995470047},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.27250000834465027},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.2680000066757202},{"id":"https://openalex.org/C2909703345","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychotropic Agent","level":2,"score":0.26460000872612},{"id":"https://openalex.org/C188313352","wikidata":"https://www.wikidata.org/wiki/Q119697","display_name":"Off-label use","level":2,"score":0.26420000195503235},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.2531999945640564},{"id":"https://openalex.org/C2909738485","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anti-Anxiety Agents","level":3,"score":0.2529999911785126}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/145986","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2440/145986","pdf_url":"https://digital.library.adelaide.edu.au/server/api/core/bitstreams/bf8fa4ce-337f-41fd-8e31-419121641bb7/content","source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"}],"best_oa_location":{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/145986","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2440/145986","pdf_url":"https://digital.library.adelaide.edu.au/server/api/core/bitstreams/bf8fa4ce-337f-41fd-8e31-419121641bb7/content","source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7216796276.pdf","grobid_xml":"https://content.openalex.org/works/W7216796276.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200488908","https://openalex.org/W4309918090","https://openalex.org/W4388573257","https://openalex.org/W4376564289","https://openalex.org/W2756442704","https://openalex.org/W2005448949","https://openalex.org/W1992576609","https://openalex.org/W2551318171","https://openalex.org/W2622954925","https://openalex.org/W2067911406"],"abstract_inverted_index":{"Prescribing":[0],"of":[1,21,50,76,85,88,114,136,146,183,197,201,312,335,341,356,374,386,430,446],"psychotropic":[2,33,51,147,190,347,461,482],"drugs":[3,23,218,288],"to":[4,35,47,55,132,155,210,316,324,417,421,453,463,477],"children":[5,36,58,325,464],"and":[6,19,37,101,143,178,238,286,326,358,366,410,465,488],"adolescents":[7,38,327,466],"has":[8],"increased":[9,309],"worldwide":[10],"over":[11],"several":[12],"decades":[13],"despite":[14],"concerns":[15],"about":[16],"the":[17,67,83,153,187,198,252,283,349,479,485],"safety":[18],"effectiveness":[20],"these":[22],"in":[24,39,66,82,206,255,314,318,331,351,363,377,428,467,481,484],"paediatric":[25,486],"populations.":[26],"To":[27],"date,":[28],"no":[29],"studies":[30],"have":[31],"examined":[32,107,112,152],"prescribing":[34,52,120,137,185,207,256,266,271,308,355,462,483],"Australian":[40,468],"primary":[41,69,469],"care":[42,70,470],"settings.":[43,471],"This":[44,73,457],"thesis":[45,74,458],"aims":[46],"examine":[48],"patterns":[49,113],"from":[53,208,310],"2011":[54,131,209,315],"2018":[56],"for":[57,164,186,216,455],"aged":[59],"0-18":[60],"years,":[61],"using":[62],"electronic":[63],"health":[64,375,473,490],"records":[65],"large":[68],"database,":[71],"MedicineInsight.":[72],"consisted":[75],"three":[77],"main":[78],"studies.":[79],"Firstly,":[80],"trends":[81,480],"prevalence":[84],"five":[86,199],"classes":[87,191,200],"psychotropics":[89,202],"were":[90,160,321,344],"examined:":[91],"antidepressants,":[92,284],"antipsychotics,":[93],"attention":[94],"deficit":[95],"hyperactivity":[96],"disorder":[97],"(ADHD)":[98],"drugs,":[99],"anxiolytics":[100],"sedatives/hypnotics.":[102],"The":[103,109,149,181,212,248],"neurohormone":[104],"melatonin":[105,359],"was":[106,141,192,215,290,360,381,400,434],"separately.":[108],"second":[110],"study":[111,151],"antipsychotic":[115,350,419],"prescribing,":[116],"focusing":[117],"on":[118],"off-label":[119,184],"(for":[121],"conditions":[122],"not":[123],"approved":[124],"by":[125,138,228,406],"Australia\u2019s":[126],"drug":[127],"regulatory":[128],"body)":[129],"comparing":[130],"2017.":[133,319],"An":[134],"examination":[135],"social":[139],"disadvantage":[140,304],"included,":[142],"an":[144,204,439],"analysis":[145],"co-prescribing.":[148],"third":[150],"extent":[154,182],"which":[156],"patients":[157,299,313,343,378,431],"receiving":[158,300,379],"antipsychotics":[159,229,285,307,380,433],"undergoing":[161],"guideline-recommended":[162],"monitoring":[163,168,429,447],"adverse":[165],"events.":[166],"Health":[167],"included":[169],"weight,":[170],"waist":[171],"circumference,":[172],"blood":[173,175,407],"pressure,":[174],"lipids,":[176],"glucose":[177,411],"liver":[179],"function.":[180],"other":[188],"four":[189],"also":[193,361],"briefly":[194],"examined.":[195],"Three":[196],"demonstrated":[203],"increase":[205,214,254,293,427],"2018.":[211],"largest":[213],"ADHD":[217,287],"(+9.6%,":[219],"95%":[220,231,241,258,275],"CI":[221,232,242,259,276],"[8.8,":[222],"10.5]":[223],"annual;":[224,235,245,262,279],"overall":[225,236,246,263,280],"95.8%),":[226],"followed":[227,405],"(+6.2%,":[230],"[5.1,":[233],"7.2]":[234],"+62.8%)":[237],"antidepressants":[239,357],"(+4.5%,":[240],"[4.0,":[243],"5.0]":[244],"+42.8%).":[247],"neurohormone,":[249],"melatonin,":[250],"showed":[251],"highest":[253],"(+24.7%,":[257],"[23.7,":[260],"25.8]":[261],"+606.7%).":[264],"Anxiolytic":[265],"remained":[267],"stable,":[268],"while":[269],"sedative/hypnotic":[270],"declined":[272],"significantly":[273],"(-6.5%,":[274],"[-8.0,":[277],"-5.0]":[278],"-40.2%)":[281],"For":[282],"there":[289],"a":[291,423],"monotonic":[292],"across":[294],"IRSAD":[295],"quintiles,":[296],"with":[297,328,348,443],"more":[298],"prescriptions":[301],"as":[302],"socio-economic":[303],"increased.":[305],"Off-label":[306,354],"69.8%":[311],"79.7%":[317],"Antipsychotics":[320],"mainly":[322],"prescribed":[323],"depression/anxiety":[329],"diagnoses":[330],"both":[332,352],"years":[333],"(26.8%":[334],"patients,":[336],"2011;":[337],"30.8%,":[338],"2017).":[339],"70%":[340],"all":[342],"co-prescribed":[345],"another":[346],"years.":[353],"prevalent":[362],"general":[364],"practice,":[365],"largely":[367],"guideline-concordant,":[368],"although":[369],"near":[370],"100%":[371],"off-label.":[372],"Monitoring":[373],"parameters":[376],"low.":[382],"Within":[383],"12":[384,450],"months":[385],"incident":[387],"prescription,":[388],"55.9%":[389],"had":[390],"at":[391,396],"least":[392,397],"one":[393],"parameter":[394],"measured":[395,401],"once.":[398],"Weight":[399],"most":[402],"frequently":[403],"(39.1%),":[404],"pressure":[408],"(29.0%)":[409],"(12.9%).":[412],"Using":[413],"target":[414],"trial":[415],"methodology":[416],"compare":[418],"users":[420,437],"non-users,":[422],"significant":[424],"but":[425],"small":[426],"starting":[432],"observed.":[435],"Antipsychotic":[436],"recorded":[438],"average":[440],"1.157":[441],"visits":[442],"any":[444],"kind":[445],"occurring":[448],"within":[449],"months,":[451],"compared":[452],"0.691":[454],"non-users.":[456],"highlights":[459],"problematic":[460],"Public":[472],"initiatives":[474],"are":[475],"needed":[476],"curb":[478],"population":[487],"improve":[489],"outcome":[491],"monitoring.":[492]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-10-03T00:00:00"}